Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Microbicides news

Show

From To
DAIDS Boss Muses on the Future of HIV Prevention Research

Below are some of Dr. Dieffenbach’s rather intentionally provocative ideas about specific HIV prevention research candidates—challenges and promises, and the questions they may raise for the next clinical trial research network structure.

Published
10 hours ago
From
AVAC
Population Council Advances Non-Antiretroviral Multipurpose Prevention Technology For HIV and STI Prevention to Clinical Trial

First in-human clinical trial of griffithsin, a naturally occurring anti-HIV protein, which limits risk of cross-resistance to antiretroviral (ARV) products.

Published
16 October 2017
From
Population Council
Free Your (and Carl's) Mind: An Open Letter to Anthony Fauci About HIV Prevention Research Priorities

Please Tony, help Carl free his mind to consider microbicides with the same passion and intensity and commitment he has for vaccines and long-acting formulations. He has heard us say these things many times over this year, but he has yet to really listen, I am sorry to say. He seems to listen only when it fits in with his vision.

Published
11 October 2017
From
The Body Pro
Save Microbicide Research and Development

Ongoing funding and support for vaginal and rectal microbicide research and development is in serious danger! Let NIAID know you want the research to continue.

Published
18 September 2017
From
IRMA
Dapivirine vaginal ring safe, acceptable for HIV prevention in teens

A monthly vaginal ring containing the antiretroviral dapivirine has demonstrated efficacy in girls younger than 18 years, according to phase 2a study results presented at the IAS Conference on HIV Science.

Published
27 July 2017
From
Healio
Rectal products for PrEP: Are they an option?

At the IAS 2017 conference this week, Ian McGowan, MD, PhD, FRCP, from University of Pittsburgh, discussed the need for (and challenges associated with) topical HIV prevention products, and a separate team of researchers presented promising findings from a very early study of a rectal HIV-prevention douche.

Published
27 July 2017
From
BETA blog
IPM receives award of up to $25 million From USAID to advance HIV prevention products for women

The award will expedite the potential licensure and market introduction of a new HIV prevention microbicide product for women, who continue to be disproportionately affected by the global HIV/AIDS epidemic.

Published
26 July 2017
From
Eurekalert Medicine & Health
IPM receives multi-year award from UK government to advance technologies for women's HIV

The nonprofit International Partnership for Microbicides (IPM) announced today that it has received a £12 million (US$15.6 million) award over four years from the United Kingdom government through the Department for International Development to advance promising HIV and multipurpose prevention products that women could use to protect their sexual and reproductive health.

Published
20 July 2017
From
Eurekalert Medicine & Health
Men often control use of women’s HIV prophylactic gel in Zambia

In Zambia, men often control the use of a microbicide gel that is meant to give women autonomy in preventing HIV infection, according to researchers. Use of the vaginal gel, which is now in phase 3 trials, is limited by social norms that entrench male dominance, they wrote in Global Public Health.

Published
17 July 2017
From
Healio
IPM's dapivirine vaginal ring now under review by European Medicines Agency

The nonprofit International Partnership for Microbicides (IPM) is pleased to announce that its application for the monthly dapivirine vaginal ring, designed to reduce the risk of HIV-1 infection via vaginal intercourse in HIV-negative women in combination with safer sex practices, has been validated and is now under review by the European Medicines Agency (EMA).

Published
14 July 2017
From
Eurekalert Medicine & Health
← First12345...25Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.